NCT01753258

Brief Summary

The focus of this pilot study is to determine if a woman who experiences pain during sexual intercourse has a higher risk of complications during labor and delivery secondary to pelvic floor dysfunction, anxiety and intolerance towards pelvic examinations. Furthermore, it is unclear whether women with prepartum dyspareunia experience an improvement following vaginal delivery. While physicians may expect that vaginal birth improves dyspareunia due to the stretching effect on pelvic floor, to date, there is insufficient evidence to support this claim. The Investigators plan to prospectively study 200 patients at our Institution, collect information regarding birth and follow them, via questionnaires, regarding their dyspareunia postpartum.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
173

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2013

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 12, 2012

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 20, 2012

Completed
12 days until next milestone

Study Start

First participant enrolled

January 1, 2013

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2016

Completed
Last Updated

October 11, 2016

Status Verified

October 1, 2016

Enrollment Period

3.7 years

First QC Date

December 12, 2012

Last Update Submit

October 10, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Obstetrical outcome of women with a history of dyspareunia

    The Investigators will record the mode of delivery (vaginal, instrumental or cesarean section), length of the second stage of labor, use of anesthetics, perineal tears and\\or episiotomies, and newborn's birth weight. The evaluation will be done prospectively, comparing data with matched controls without a history of dyspareunia.

    3 months -1 year

Secondary Outcomes (1)

  • Rate of alleviation of dyspareunia following vaginal delivery as assessed through patient questionnaires.

    2 years

Study Arms (3)

Definite diagnosis of dyspareunia

Patients who report dyspareunia, and whose dyspareunia was evaluated prior to delivery by a caregiver experienced with sexual pain disorders, with definite diagnosis.

No definite diagnosis of dyspareunia

Patients who report dyspareunia but were not evaluated prior to delivery or were evaluated inappropriately (i.e. "yeast infection" without cultures, "inflammation" and other vague definitions).

Patients without dyspareunia

Patients without dyspareunia- those who report non painful sexual intercourse. This group of patients will be used as a control group.

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Nulliparous women admitted to the Labor and Delivery Department at the Hadassah Medical Center, above the age of 18

You may qualify if:

  • nulliparous women admitted to the Labor and Delivery Department at the Hadassah Medical Center, above the age of 18.
  • Able and willing to read, understand, and sign the Informed Consent Form and questionnaire.
  • Agree to be contacted in the future to complete telephone questionnaires.

You may not qualify if:

  • Induction of labor
  • Placental abruption, placenta previa
  • Malpresentation
  • Non reassuring fetal heart rate upon admission
  • Any other contraindication for vaginal delivery
  • Multifetal pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hadassah Medical Organization

Jerusalem, Israel

Location

MeSH Terms

Conditions

Dyspareunia

Condition Hierarchy (Ancestors)

Genital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesGenital Diseases, MaleSexual Dysfunction, PhysiologicalMale Urogenital DiseasesSexual Dysfunctions, PsychologicalMental Disorders

Study Officials

  • Ahinoam Lev-Sagie, MD

    Hadassah Medical Organization

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 12, 2012

First Posted

December 20, 2012

Study Start

January 1, 2013

Primary Completion

September 1, 2016

Study Completion

September 1, 2016

Last Updated

October 11, 2016

Record last verified: 2016-10

Locations